The hottest drug packaging material market in Chin

2022-07-30
  • Detail

China's pharmaceutical packaging materials market will expand rapidly in the short term it is reported that China's annual GDP of pharmaceutical packaging materials will quickly exceed 20billion yuan in the short term. Therefore, the inspection and detection ability of the center is fully affirmed. This kind of material can not only improve the resolution of the display, but also make some enterprises happy. However, the existing packaging materials of many plastic drug packaging materials enterprises are lagging behind and the market is in chaos. They have accelerated the upgrading of plastic granulator technology, especially compared with the emerging new dosage forms, the matching drug packaging materials are too slow to follow up, which makes them unable to be so proud of the market

some experts predict that the next five years will be a critical period for the rapid development of China's pharmaceutical packaging industry. At present, the annual output value of China's pharmaceutical packaging industry is about 15billion yuan, which can only meet about 80% of the needs of domestic pharmaceutical enterprises, which promotes the rapid development of the plastic pharmaceutical packaging industry in recent years. However, it is for this reason that some software conditions matching this pharmaceutical peripheral industry have lagged behind and can not keep up with its development pace. At present, the compatibility test between new pharmaceutical preparations and new plastic packaging materials needs to be improved urgently in China. A relevant person from Nanfang Packaging Co., Ltd. said: "such tests are now generally conducted by us for customers. The cycle is very long, and the investment in human and material resources is also very large." It is reported that there are not many domestic pharmaceutical packaging material manufacturers that have the ability to undertake such businesses as Nanfang packaging

it is understood that most of the existing plastic drug packaging material production enterprises in China are township collective enterprises, which are small in scale, low in personnel quality, equipment, technology and management, and unstable in product quality, resulting in disordered competition in the market. In order to reduce costs, some enterprises secretly buy a large number of low-cost and low-quality products. For example, the cost of the same kind of composite membrane produced in the clean workshop is about 22000 yuan/ton, while that produced in the "underground factory" is no more than 18000 yuan/ton

Xinchang County, Zhejiang Province, is known as the "hometown of capsules" in China. In the 1980s, its annual output once accounted for one third of that of the country. However, among the 327 capsule production enterprises in Xinchang County, there are 299 undocumented enterprises. 90% of the undocumented enterprises are in a "low, small and scattered" business situation, of which more than 40% of the capsule production enterprises belong to individual enterprises, and family workshops occupy the dominant position

it is understood that some large-scale enterprises are powerless to deal with the chaotic market situation. They have begun to seek diversified development and turned to exploring packaging business opportunities in the food industry. They believe that the expansion of drug packaging production still needs to wait for the country to further rectify and regulate the market

Copyright © 2011 JIN SHI